Revelation Biosciences (REVB) Change in Accured Expenses (2020 - 2026)
Revelation Biosciences (REVB) posted Change in Accured Expenses of $291,855 for Q2 2026, up 5.7% from $275,994 a year earlier.
Powered by 
Analysis
Revelation Biosciences (REVB) Change in Accured Expenses (2020 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Change in Accured Expenses at Revelation Biosciences was $20,223; for FY2025, it was $269,756.
- Annual Change in Accured Expenses shows a five-year compound annual growth rate of 51.5% (FY2020 to FY2025).
- In prior years, Revelation Biosciences' Change in Accured Expenses was -$2.94 million in FY2024, $161,963 in FY2023, -$592,987 in FY2022 and $1.19 million in FY2021.
- Quarterly Change in Accured Expenses has run from a low of -$8.9 million in Q3 2024 to a high of $6.31 million in Q2 2024 over five years.
- On a year-over-year basis, Change in Accured Expenses increased in three of the last four quarters, with growth averaging 48.7%.
- According to Business Quant data, Change in Accured Expenses for the three prior quarters was -$929,562 (Q1 2026), $604,341 (Q4 2025) and $53,589 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 2.96 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -251.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Revelation Biosciences | 3.01 Mn | -46.01 Mn | - | 291,855.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 291,855.00 |
| Mar 31, 2026 | -929,562.00 |
| Dec 31, 2025 | 604,341.00 |
| Sep 30, 2025 | 53,589.00 |
| Jun 30, 2025 | 275,994.00 |
| Mar 31, 2025 | -664,168.00 |
| Dec 31, 2024 | 193,428.00 |
| Sep 30, 2024 | -8.90 Mn |
| Jun 30, 2024 | 6.31 Mn |
| Mar 31, 2024 | -532,180.00 |
| Dec 31, 2023 | 112,325.00 |
| Sep 30, 2023 | 525,165.00 |
| Jun 30, 2023 | -477,055.00 |
| Mar 31, 2023 | 1,528.00 |
| Dec 31, 2022 | -24,050.00 |
| Sep 30, 2022 | -423,081.00 |
| Jun 30, 2022 | -1.54 Mn |
| Mar 31, 2022 | 1.39 Mn |
| Dec 31, 2021 | 378,470.00 |
| Sep 30, 2021 | 430,267.00 |
API Access
Revelation Biosciences Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=REVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "REVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=REVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();